<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01287013</url>
  </required_header>
  <id_info>
    <org_study_id>110082</org_study_id>
    <secondary_id>110082</secondary_id>
    <nct_id>NCT01287013</nct_id>
  </id_info>
  <brief_title>Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures</brief_title>
  <official_title>Prospective Randomized Trial Comparing Navigation With Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institutes of Health Clinical Center (CC)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:

      - Procedures that use medical tools in or near a possible abnormality in the body often use
      computed tomography (CT) scans to locate the abnormality and guide the path that a needle
      will take to collect a sample of tissue. Xperguide and electromagnetic (EM) tracking are two
      new procedures being studied to help guide the needle. Xperguide is software that uses CT
      images to help the doctor choose the needle path. EM tracking uses special medical tools with
      miniature coils that act like a Global Positioning Satellite (GPS) device to show the
      location of the needle in the body. Xperguide and EM tracking have been used in humans and
      have good results, but they have not been compared with each other and regular CT to
      determine whether they are better than the standard approach.

      Objectives:

      - To compare the results of Xperguide, electromagnetic tracking, and regular computed
      tomography during a guided percutaneous procedure.

      Eligibility:

      - Individuals at least 18 years of age who are required to have a CT-guided percutaneous
      procedure.

      Design:

        -  Participants will be screened with a physical examination and medical history, and the
           results of any previous imaging studies will be examined before study enrollment.

        -  After a pilot phase, the study will involve two phases to compare the results of the
           different procedures. The first phase will involve comparing Xperguide to CT, and the
           second will involve comparing Xperguide to EM tracking.

        -  Phase 1 participants will be assigned to one of two procedure groups: Group 1 will have
           Xperguide, and Group 2 will have regular CT. Participants who are scheduled to have
           repeated procedures (like a biopsy before and after chemotherapy) will be randomized for
           the first procedure and the second procedure will be done using the other method.

        -  Phase 2 participants will be assigned to one of two procedure groups: Group 1 will have
           Xperguide, and Group 2 will have EM tracking. Participants who are scheduled to have
           repeated procedures (like a biopsy before and after chemotherapy) will be randomized for
           the first procedure and the second procedure will be done using the other method.

        -  Standard post-procedure followup care will be given after the study procedure is
           completed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PR(SqrRoot) CIS

      This is a phase II prospective randomized trial comparing a novel navigation method,
      Xperguide to conventional CT and electromagnetic tracking (EM) during percutaneous image
      guided procedures. Xperguide is a navigation tool that utilizes a cone beam CT (CBCT)
      obtained in the angiography suite overlaid on fluoroscopy for needle guidance during image
      guided procedures. The needle entry point and path are planned on the CBCT and the determined
      path is overlaid on fluoroscopy image for real time guidance.

      SPECIFIC AIMS/OBJECTIVES

        1. The primary aims are:

           a. Pilot trial:

           i. To familiarize operators with outcome measures allowing for fair comparison in the
           subsequent study

           b. Main trial will have 2 phases with similar outcomes criteria and aims (below):

           i. comparing Xperguide to conventional imaging (superiority design):

      ii. comparing Xperguide to EM tracking (equivalence design):

        1. To compare the accuracy of final device tip position and path (vector)

        2. To compare the number of repositioning maneuvers

        3. To compare the radiation dose

        4. To compare rates of definitive pathological diagnosis and response rate per EASL
           criteria for ablations

      METHODS/METHODOLOGY

      For non-vascular image guided interventions, patients undergoing biopsies and ablations
      procedures requiring CT guidance are eligible for inclusion and randomization. An initial
      pilot study will be done in which each operator will perform at least 5 cases using Xperguide
      completing the case report forms. This will ensure experience with outcome measures and fair
      comparison in the subsequent study. Once one of the operators reaches the minimal required
      cases, the main trial will begin for that operator. However every other operator must each
      complete the minimal number of cases with the case report forms to enroll patients in the
      main trial. Initially, we will compare Xperguide with conventional CT with several cohorts of
      patients mainly: lung biopsies, and ablations, kidney biopsies/ablations and other abdominal
      biopsies/ ablations. In ablations of large lesions, Xperguide composite ablation software can
      provide input on the expected ablation zones. Each probe will be positioned in the same
      manner as any biopsy needle following steps described in section 4. If this specific
      composite ablation module of the

      software is not commercially released and FDA cleared at the time of the study, then this
      software will only be used on protocol to help the physician determine ideal needle
      positioning for complete ablation. Once consent is obtained the participant is randomized to
      either conventional imaging or Xperguide. In addition, if it is known that the patient is
      participating in a trial which requires a repeat (paired, pre and post treatment) procedure
      of the same site, then the randomization will determine which modality is used for guidance
      at the first visit and the other modality will automatically be used for the second
      procedure. In these cases, if the patient gives consent they will be randomized to one of two
      categories:

        1. Xperguide for the initial procedure and conventional CT for the 2nd procedure

        2. Conventional CT for the initial procedure and Xperguide for the 2nd procedure

      Then in the second phase of the trial, Xperguide will be compared to EM tracking for biopsies
      and ablations requiring CT guidance, in an equivalence study. Once consent is obtained, the
      participant will be randomized into EM tracking or Xperguide. The patients would be divided
      into different cohorts depending on the anatomic site of the interventions i.e. lung, kidney,
      liver and other abdomen. If the patients are participating in a trial requiring paired
      procedures (i.e. pre and post treatment), the randomization will determine which modality is
      used for the initial procedure and the other modality will be used for the second procedure.
      In summary there will be two potential categories:

        1. EM tracking for the initial procedure and Xperguide for the 2nd procedure

        2. Xperguide for the initial procedure and EM tracking for the 2nd procedure

      If a patient has a lesion that is only visible on PET-CT/MR, or demonstrates heterogenous
      PET-CT/MR uptake, there will be a separate cohort of PET-CT/MR guided biopsies and ablations
      using Xperguide vs EM tracking. There is also the need for a cohort for ablations with
      complimentary use of ultrasound at the discretion of the operator in order to conform to our
      standard of care at the NIH.

      ELIGIBILITY

      Subjects are eligible if:

        1. they are over 18 years of age

        2. they are scheduled for image guided procedure

        3. the lesion is not superficial (deeper than 3cm)

      Subjects are excluded if:

        1. they have an altered mental status that precludes understanding or consenting for the
           procedure

        2. they are unable to hold reasonably still on a procedure table for the length of the
           procedure

        3. they are unable to hold their breath if the procedure will be performed with conscious
           sedation and without general anesthesia

        4. their gross body weight is over 375 pounds which the upper limit of the CT and

      angiography tables

      REQUIRED SAMPLE SIZE

      A pilot study will be performed to ensure operator experience with Xperguide and EM tracking,
      for fair comparison. In the pilot study each operator must perform 5 cases with Xperguide
      completing the case report forms. There are 5 potential operators therefore a maximum of 25
      patients (if all 5 operators participate to the fullest).

      The first phase of the main trial comparing Xperguide with conventional CT was powered (for
      sample size) with a standard superiority design aimed to statistically establish that
      Xperguide is better than conventional CT (defined as requiring fewer needle repositioning
      efforts). These calculations yield a total sample size of 60 patients with 20 patients per
      anatomical site.

      For the second phase of the trial comparing Xperguide to EM tracking, a two sided equivalence
      design (based on accuracy and number of needle repositioning) was used for sample size
      considerations, and yielded 192 patients. Therefore 16 patients per modality per anatomical
      site will be randomized with two additional cohorts for PET-CT/MR procedures and composite
      ablations.

      Number of Participants: 277

      Recruitment Time Frame: 4 years

      Number of sites: 1

      Type of Study: prospective randomized clinical trial after an initial pilot period
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Investigator left NIH
  </why_stopped>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparing the Accuracy of Final Device Tip Position</measure>
    <time_frame>1 hour</time_frame>
    <description>To compare the accuracy of the biopsy needle between the software guidance and conventional CT. The accuracy of the needle position was calculated in millimeters by using the difference between the x,y,z coordinates of the tip of the actual needle before specimen collection. Actual and planned needle paths were compared using coordinates and measured in millimeters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy of Final Device Path (Vector)</measure>
    <time_frame>1 hour</time_frame>
    <description>Comparing the accuracy of the path the biopsy needle took to get to the site</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiation Doses Between Xperguide and Conventional CT</measure>
    <time_frame>1 hour</time_frame>
    <description>Comparing radiation doses to determine if there is a change in the dose between the two interventions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the Number of Repositioning Maneuvers</measure>
    <time_frame>1 hour</time_frame>
    <description>To compare the number of times the needle must be repositioned during the guidance of the needle to the biopsy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of Definitive Pathologic Diagnosis</measure>
    <time_frame>1 hour</time_frame>
    <description>Definitive pathologic diagnosis was defined as an adequate specimen as judged by the pathologist and a diagnosis confirmed by surgery or clinical follow-up.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Infection</condition>
  <condition>Cancer</condition>
  <condition>Neoplasm</condition>
  <condition>Empyema</condition>
  <condition>Granuloma</condition>
  <arm_group>
    <arm_group_label>Cone Beam CT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional CT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cone-beam computed tomography (CT)</intervention_name>
    <description>Imaging</description>
    <arm_group_label>Cone Beam CT</arm_group_label>
    <other_name>XperCT (Philips, Best)</other_name>
    <other_name>XperGuide CT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional Computed Tomography (CT)</intervention_name>
    <description>Imaging</description>
    <arm_group_label>Conventional CT</arm_group_label>
    <other_name>Conventional CT (Philips)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

               1. they are over 18 years of age

               2. they are scheduled for image guided procedure

               3. the lesion is not superficial (deeper than 3 cm)

        EXCLUSION CRITERIA:

          1. patients with an altered mental status that precludes understanding or consenting for
             the procedure

          2. patients unable to hold reasonably still on a procedure table for the length of the
             procedure

          3. patient unable to hold their breath if the procedure will be performed with conscious
             sedation and without general anesthesia

          4. patient with a gross body weight over 375 pounds (upper limit of the CT and
             angiography tables)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradford Wood, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institutes of Health Clinical Center (CC)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_2011-CC-0082.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Carrafiello G, Mangini M, De Bernardi I, Fontana F, Dionigi G, Cuffari S, Imperatori A, Lagan√† D, Fugazzola C. Microwave ablation therapy for treating primary and secondary lung tumours: technical note. Radiol Med. 2010 Sep;115(6):962-74. doi: 10.1007/s11547-010-0547-7. Epub 2010 Mar 29. English, Italian.</citation>
    <PMID>20352357</PMID>
  </reference>
  <reference>
    <citation>Racadio JM, Babic D, Homan R, Rampton JW, Patel MN, Racadio JM, Johnson ND. Live 3D guidance in the interventional radiology suite. AJR Am J Roentgenol. 2007 Dec;189(6):W357-64. Review.</citation>
    <PMID>18029850</PMID>
  </reference>
  <reference>
    <citation>Spelle L, Ruijters D, Babic D, Homan R, Mielekamp P, Guillermic J, Moret J. First clinical experience in applying XperGuide in embolization of jugular paragangliomas by direct intratumoral puncture. Int J Comput Assist Radiol Surg. 2009 Nov;4(6):527-33. doi: 10.1007/s11548-009-0370-6. Epub 2009 Jun 13.</citation>
    <PMID>20033329</PMID>
  </reference>
  <results_reference>
    <citation>Abi-Jaoudeh N, Fisher T, Jacobus J, Skopec M, Radaelli A, Van Der Bom IM, Wesley R, Wood BJ. Prospective Randomized Trial for Image-Guided Biopsy Using Cone-Beam CT Navigation Compared with Conventional CT. J Vasc Interv Radiol. 2016 Sep;27(9):1342-1349. doi: 10.1016/j.jvir.2016.05.034. Epub 2016 Jul 25.</citation>
    <PMID>27461586</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2011</study_first_submitted>
  <study_first_submitted_qc>January 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2011</study_first_posted>
  <results_first_submitted>August 4, 2016</results_first_submitted>
  <results_first_submitted_qc>December 4, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">January 5, 2018</results_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Image Guided Procedures</keyword>
  <keyword>Xperguide CT</keyword>
  <keyword>Electromagnetic Tracking</keyword>
  <keyword>Navigation</keyword>
  <keyword>Image Guided Procedure</keyword>
  <keyword>Cancer</keyword>
  <keyword>Granuloma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Granuloma</mesh_term>
    <mesh_term>Empyema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment period = 2/4/2011 - 5/15/2014 Recruitment location = Interventional Radiology Clinic, Department of Radiology and Imaging Sciences, Clinical Center, NIH</recruitment_details>
      <pre_assignment_details>The PILOT Arm of the study was done prior to enrolling participants in the main phase of the study. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures. Participants enrolled in the PILOT Arm were not randomized to either the Cone Beam CT or Conventional CT Arms and not included in the analysis.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Cone Beam CT</title>
          <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
        </group>
        <group group_id="P2">
          <title>Conventional CT</title>
          <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
        </group>
        <group group_id="P3">
          <title>PILOT</title>
          <description>Procedures performed with Xperguide without randomization to familiarize operators.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="34"/>
                <participants group_id="P3" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="29"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="21"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Non-evaluable</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="21"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cone Beam CT</title>
          <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
        </group>
        <group group_id="B2">
          <title>Conventional CT</title>
          <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
        </group>
        <group group_id="B3">
          <title>PILOT</title>
          <description>Procedures performed with Xperguide without randomization to familiarize operators.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="21"/>
            <count group_id="B4" value="87"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comparing the Accuracy of Final Device Tip Position</title>
        <description>To compare the accuracy of the biopsy needle between the software guidance and conventional CT. The accuracy of the needle position was calculated in millimeters by using the difference between the x,y,z coordinates of the tip of the actual needle before specimen collection. Actual and planned needle paths were compared using coordinates and measured in millimeters.</description>
        <time_frame>1 hour</time_frame>
        <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
        <group_list>
          <group group_id="O1">
            <title>Cone Beam CT</title>
            <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
          </group>
          <group group_id="O2">
            <title>Conventional CT</title>
            <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
          </group>
        </group_list>
        <measure>
          <title>Comparing the Accuracy of Final Device Tip Position</title>
          <description>To compare the accuracy of the biopsy needle between the software guidance and conventional CT. The accuracy of the needle position was calculated in millimeters by using the difference between the x,y,z coordinates of the tip of the actual needle before specimen collection. Actual and planned needle paths were compared using coordinates and measured in millimeters.</description>
          <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="4.1"/>
                    <measurement group_id="O2" value="12.2" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Accuracy of Final Device Path (Vector)</title>
        <description>Comparing the accuracy of the path the biopsy needle took to get to the site</description>
        <time_frame>1 hour</time_frame>
        <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
        <group_list>
          <group group_id="O1">
            <title>Cone Beam CT</title>
            <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
          </group>
          <group group_id="O2">
            <title>Convetional CT</title>
            <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
          </group>
        </group_list>
        <measure>
          <title>Accuracy of Final Device Path (Vector)</title>
          <description>Comparing the accuracy of the path the biopsy needle took to get to the site</description>
          <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="5.4"/>
                    <measurement group_id="O2" value="28.3" spread="20.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Radiation Doses Between Xperguide and Conventional CT</title>
        <description>Comparing radiation doses to determine if there is a change in the dose between the two interventions</description>
        <time_frame>1 hour</time_frame>
        <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
        <group_list>
          <group group_id="O1">
            <title>Cone Beam CT</title>
            <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
          </group>
          <group group_id="O2">
            <title>Conventional CT</title>
            <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
          </group>
        </group_list>
        <measure>
          <title>Radiation Doses Between Xperguide and Conventional CT</title>
          <description>Comparing radiation doses to determine if there is a change in the dose between the two interventions</description>
          <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
          <units>mGy</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.3" spread="33.3"/>
                    <measurement group_id="O2" value="75.4" spread="62.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.04</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Compare the Number of Repositioning Maneuvers</title>
        <description>To compare the number of times the needle must be repositioned during the guidance of the needle to the biopsy.</description>
        <time_frame>1 hour</time_frame>
        <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
        <group_list>
          <group group_id="O1">
            <title>Cone Beam CT</title>
            <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
          </group>
          <group group_id="O2">
            <title>Conventional CT</title>
            <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
          </group>
        </group_list>
        <measure>
          <title>Compare the Number of Repositioning Maneuvers</title>
          <description>To compare the number of times the needle must be repositioned during the guidance of the needle to the biopsy.</description>
          <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
          <units>number of repositioning maneuvers</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.5"/>
                    <measurement group_id="O2" value="1.9" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rates of Definitive Pathologic Diagnosis</title>
        <description>Definitive pathologic diagnosis was defined as an adequate specimen as judged by the pathologist and a diagnosis confirmed by surgery or clinical follow-up.</description>
        <time_frame>1 hour</time_frame>
        <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
        <group_list>
          <group group_id="O1">
            <title>Cone Beam CT</title>
            <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
          </group>
          <group group_id="O2">
            <title>Conventional CT</title>
            <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
          </group>
        </group_list>
        <measure>
          <title>Rates of Definitive Pathologic Diagnosis</title>
          <description>Definitive pathologic diagnosis was defined as an adequate specimen as judged by the pathologist and a diagnosis confirmed by surgery or clinical follow-up.</description>
          <population>Participants enrolled in the PILOT Arm were not randomized to the Cone Beam CT or Conventional CT Arms and were not included in the analysis. PILOT Participants were enrolled to familiarize operators with performing Xperguide procedures.</population>
          <units>percent of accuracy</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.9"/>
                    <measurement group_id="O2" value="90.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=0.67</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 day</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cone Beam CT</title>
          <description>Procedure performed with Xperguide cone-beam Computed Tomography (CT) navigation</description>
        </group>
        <group group_id="E2">
          <title>Conventional CT</title>
          <description>Procedure performed with Conventional Computed Tomography (CT) image guidance</description>
        </group>
        <group group_id="E3">
          <title>Pilot Arm</title>
          <description>Pilot participants were enrolled to familiarize operators with performing Xperguide procedures.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="29"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <description>Grade 3. Possibly related to research (procedure). Patient was hospitalized for 3 days for a small left apical pneumothorax increased since immediate post lung biopsy verified by chest CT. A chest tube had to be placed in IR after the biopsy.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="29"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Bradford Wood, MD</name_or_title>
      <organization>National Institutes of Health</organization>
      <phone>(301) 496-7739</phone>
      <email>bwood@nih.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

